XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Anti-dilutive stock awards were as follows for the periods presented:
Quarter Ended
September 30,
Nine Months Ended
September 30,
(in thousands)2024202320242023
Stock awards333 333 334 373 
Total333 333 334 373 
Basic And Diluted Earnings Per Share
The following table presents the earnings per share calculation for the periods presented:
 Quarter Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Net Income (in millions)
$912.8 $750.2 $2,651.2 $2,411.6 
Less: preferred stock dividends(5.3)(5.0)(15.8)(15.1)
Less: undistributed earnings allocated to preferred stock(6.2)(4.4)(17.6)(15.2)
Net Income Attributable to Common Shareholders of CME Group$901.3 $740.8 $2,617.8 $2,381.3 
Weighted Average Number of Common Shares (in thousands):
Basic359,400 359,020 359,329 358,965 
Effect of stock options, restricted stock and performance shares589 599 570 483 
Diluted359,989 359,619 359,899 359,448 
Earnings per Common Share Attributable to Common Shareholders of CME Group:
Basic$2.51 $2.06 $7.29 $6.63 
Diluted2.50 2.06 7.27 6.62